Cargando…

Thymoquinone and Difluoromethylornithine (DFMO) Synergistically Induce Apoptosis of Human Acute T Lymphoblastic Leukemia Jurkat Cells Through the Modulation of Epigenetic Pathways

Thymoquinone (TQ), a natural anticancer agent exerts cytotoxic effects on several tumors by targeting multiple pathways, including apoptosis. Difluoromethylornithine (DFMO), an irreversible inhibitor of the ornithine decarboxylase (ODC) enzyme, has shown promising inhibitory activities in many cance...

Descripción completa

Detalles Bibliográficos
Autores principales: Alhosin, Mahmoud, Razvi, Syed Shoeb I., Sheikh, Ryan A., Khan, Jalaluddin A., Zamzami, Mazin A., Choudhry, Hani
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7488875/
https://www.ncbi.nlm.nih.gov/pubmed/32912061
http://dx.doi.org/10.1177/1533033820947489
_version_ 1783581782584590336
author Alhosin, Mahmoud
Razvi, Syed Shoeb I.
Sheikh, Ryan A.
Khan, Jalaluddin A.
Zamzami, Mazin A.
Choudhry, Hani
author_facet Alhosin, Mahmoud
Razvi, Syed Shoeb I.
Sheikh, Ryan A.
Khan, Jalaluddin A.
Zamzami, Mazin A.
Choudhry, Hani
author_sort Alhosin, Mahmoud
collection PubMed
description Thymoquinone (TQ), a natural anticancer agent exerts cytotoxic effects on several tumors by targeting multiple pathways, including apoptosis. Difluoromethylornithine (DFMO), an irreversible inhibitor of the ornithine decarboxylase (ODC) enzyme, has shown promising inhibitory activities in many cancers including leukemia by decreasing the biosynthesis of the intracellular polyamines. The present study aimed to investigate the combinatorial cytotoxic effects of TQ and DFMO on human acute T lymphoblastic leukemia Jurkat cells and to determine the underlying mechanisms. Here, we show that the combination of DFMO and TQ significantly reduced cell viability and resulted in significant synergistic effects on apoptosis when compared to either DFMO or TQ alone. RNA-sequencing showed that many key epigenetic players including Ubiquitin-like containing PHD and Ring finger 1 (UHRF1) and its 2 partners DNA methyltransferase 1 (DNMT1) and histone deacetylase 1 (HDAC1) were down-regulated in DFMO-treated Jurkat cells. The combination of DFMO and TQ dramatically decreased the expression of UHRF1, DNMT1 and HDAC1 genes compared to either DFMO or TQ alone. UHRF1 knockdown led to a decrease in Jurkat cell viability. In conclusion, these results suggest that the combination of DFMO and TQ could be a promising new strategy for the treatment of human acute T lymphoblastic leukemia by targeting the epigenetic code.
format Online
Article
Text
id pubmed-7488875
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-74888752020-09-21 Thymoquinone and Difluoromethylornithine (DFMO) Synergistically Induce Apoptosis of Human Acute T Lymphoblastic Leukemia Jurkat Cells Through the Modulation of Epigenetic Pathways Alhosin, Mahmoud Razvi, Syed Shoeb I. Sheikh, Ryan A. Khan, Jalaluddin A. Zamzami, Mazin A. Choudhry, Hani Technol Cancer Res Treat Original Article Thymoquinone (TQ), a natural anticancer agent exerts cytotoxic effects on several tumors by targeting multiple pathways, including apoptosis. Difluoromethylornithine (DFMO), an irreversible inhibitor of the ornithine decarboxylase (ODC) enzyme, has shown promising inhibitory activities in many cancers including leukemia by decreasing the biosynthesis of the intracellular polyamines. The present study aimed to investigate the combinatorial cytotoxic effects of TQ and DFMO on human acute T lymphoblastic leukemia Jurkat cells and to determine the underlying mechanisms. Here, we show that the combination of DFMO and TQ significantly reduced cell viability and resulted in significant synergistic effects on apoptosis when compared to either DFMO or TQ alone. RNA-sequencing showed that many key epigenetic players including Ubiquitin-like containing PHD and Ring finger 1 (UHRF1) and its 2 partners DNA methyltransferase 1 (DNMT1) and histone deacetylase 1 (HDAC1) were down-regulated in DFMO-treated Jurkat cells. The combination of DFMO and TQ dramatically decreased the expression of UHRF1, DNMT1 and HDAC1 genes compared to either DFMO or TQ alone. UHRF1 knockdown led to a decrease in Jurkat cell viability. In conclusion, these results suggest that the combination of DFMO and TQ could be a promising new strategy for the treatment of human acute T lymphoblastic leukemia by targeting the epigenetic code. SAGE Publications 2020-09-10 /pmc/articles/PMC7488875/ /pubmed/32912061 http://dx.doi.org/10.1177/1533033820947489 Text en © The Author(s) 2020 https://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Original Article
Alhosin, Mahmoud
Razvi, Syed Shoeb I.
Sheikh, Ryan A.
Khan, Jalaluddin A.
Zamzami, Mazin A.
Choudhry, Hani
Thymoquinone and Difluoromethylornithine (DFMO) Synergistically Induce Apoptosis of Human Acute T Lymphoblastic Leukemia Jurkat Cells Through the Modulation of Epigenetic Pathways
title Thymoquinone and Difluoromethylornithine (DFMO) Synergistically Induce Apoptosis of Human Acute T Lymphoblastic Leukemia Jurkat Cells Through the Modulation of Epigenetic Pathways
title_full Thymoquinone and Difluoromethylornithine (DFMO) Synergistically Induce Apoptosis of Human Acute T Lymphoblastic Leukemia Jurkat Cells Through the Modulation of Epigenetic Pathways
title_fullStr Thymoquinone and Difluoromethylornithine (DFMO) Synergistically Induce Apoptosis of Human Acute T Lymphoblastic Leukemia Jurkat Cells Through the Modulation of Epigenetic Pathways
title_full_unstemmed Thymoquinone and Difluoromethylornithine (DFMO) Synergistically Induce Apoptosis of Human Acute T Lymphoblastic Leukemia Jurkat Cells Through the Modulation of Epigenetic Pathways
title_short Thymoquinone and Difluoromethylornithine (DFMO) Synergistically Induce Apoptosis of Human Acute T Lymphoblastic Leukemia Jurkat Cells Through the Modulation of Epigenetic Pathways
title_sort thymoquinone and difluoromethylornithine (dfmo) synergistically induce apoptosis of human acute t lymphoblastic leukemia jurkat cells through the modulation of epigenetic pathways
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7488875/
https://www.ncbi.nlm.nih.gov/pubmed/32912061
http://dx.doi.org/10.1177/1533033820947489
work_keys_str_mv AT alhosinmahmoud thymoquinoneanddifluoromethylornithinedfmosynergisticallyinduceapoptosisofhumanacutetlymphoblasticleukemiajurkatcellsthroughthemodulationofepigeneticpathways
AT razvisyedshoebi thymoquinoneanddifluoromethylornithinedfmosynergisticallyinduceapoptosisofhumanacutetlymphoblasticleukemiajurkatcellsthroughthemodulationofepigeneticpathways
AT sheikhryana thymoquinoneanddifluoromethylornithinedfmosynergisticallyinduceapoptosisofhumanacutetlymphoblasticleukemiajurkatcellsthroughthemodulationofepigeneticpathways
AT khanjalaluddina thymoquinoneanddifluoromethylornithinedfmosynergisticallyinduceapoptosisofhumanacutetlymphoblasticleukemiajurkatcellsthroughthemodulationofepigeneticpathways
AT zamzamimazina thymoquinoneanddifluoromethylornithinedfmosynergisticallyinduceapoptosisofhumanacutetlymphoblasticleukemiajurkatcellsthroughthemodulationofepigeneticpathways
AT choudhryhani thymoquinoneanddifluoromethylornithinedfmosynergisticallyinduceapoptosisofhumanacutetlymphoblasticleukemiajurkatcellsthroughthemodulationofepigeneticpathways